ResMed faces headwinds from COVID inventory destocking in 2023-2024, which has pressured financial performance and caused the healthcare industry to lag the S&P 500. However, personal health and wellness remains a strong secular tailwind. As a large-cap, ResMed has scale but faces challenges finding new growth areas compared to smaller competitors.